Ads
related to: alpha-1 antitrypsin deficiency (aatd)
Search results
Vertex Moves Its Alpha-1 Antitrypsin Deficiency Program Forward
Benzinga via Yahoo Finance· 2 years agoVertex Pharmaceuticals Inc (NASDAQ: VRTX) has advanced its investigational program targeting alpha-1...
Sanofi to buy Inhibrx in deal worth up to $2.2B
BioPharma Dive via Yahoo Finance· 4 months agoThe acquisition will give Sanofi an experimental drug for alpha-1 antitrypsin deficiency, while the rest of Inhibrx's assets will be spun into a new...
Inhibrx's Experimental Drug For Inherited Disease Capable For Accelerated FDA Approval, Shares Surge
Benzinga via Yahoo Finance· 2 years agoBased on discussions with the FDA, Inhibrx Inc (NASDAQ: INBX) has the potential to pursue...
Is it a Good Idea to Invest in Intellia (NTLA) Stock Now?
Zacks via Yahoo Finance· 4 months agoIntellia Therapeutics, Inc. NTLA is a clinical-stage genome editing company focused on developing...
Why Did BMO Capital Markets Raise Price Target For Gene Stock One Month After Initiating Coverage
Benzinga via Yahoo Finance· 2 years agoBMO Capital Markets has raised the price target on Beam Therapeutics Inc (NASDAQ: BEAM) to $61 from...
EastEnders' Sam Mitchell to make major New Year discovery
Digital Spy via Yahoo News· 5 months agoEastEnders spoilers follow. EastEnders' Sam Mitchell will make a major discovery in the New Year....
2 Cutting-Edge Gene-Editing Stocks That You Don't Want to Miss
Motley Fool· 8 months agoOf course, it's complicated to figure out which are going to soar and which will languish, so it...
These 3 Biotech Stocks More Than Doubled in November. Can They Fly Even Higher in 2024?
Motley Fool· 6 months agoOn Nov. 3, Korro Bio (NASDAQ: KRRO) used Frequency Therapeutics' Nasdaq listing to reverse merge...
Vertex Pharmaceuticals Just Proved Something Big to Investors. Time to Buy?
Motley Fool· 6 months agoVertex Pharmaceuticals (NASDAQ: VRTX) has built a billion-dollar cystic fibrosis (CF) treatment...
Arrowhead Pharmaceuticals Reports Underwhelming Data From Inherited Disease Study
Benzinga via Yahoo Finance· 1 year agoTakeda Pharmaceutical Co Ltd (NYSE: TAK) and Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) announced...
Ad
related to: alpha-1 antitrypsin deficiency (aatd)alphaid.com has been visited by 10K+ users in the past month